Additionally, the effect that BTK inhibition has on myeloma cell homing and adhesion to the bone marrow can inhibit important functions in MM survival, reducing cytokine secretion and sensitizing drug resistant cells to chemotherapy [73]. The gene discussed is BTK; the disease is Miyoshi myopathy.